Parallel Advisors, LLC Biotechnology

Parallel Advisors, LLC

$4.87 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TARS Tarsus Pharmaceuticals, Inc.	$1.85B	$1,000 0.0% of portfolio	48	Q2 2025 Added 20.0%
VXRT Vaxart, Inc.	$41.7M	$1,000 0.0% of portfolio	3,000	Q2 2023 Reduced 2.45%
ACAD Acadia Pharmaceuticals Inc	$3.54B	$0 0.0% of portfolio	42	Q2 2025 Reduced 60.75%
ADAP Adaptimmune Therapeutics PLC	$8.17M	$0 0.0% of portfolio	250	Q4 2024 Reduced 96.52%
AGIO Agios Pharmaceuticals, Inc.	$2.2B	$0 0.0% of portfolio	12	Q2 2025 Reduced 97.62%
ALT Altimmune, Inc.	$194M	$0 0.0% of portfolio	40	Q3 2022 Reduced 90.91%
AURA Aura Biosciences, Inc.	$173M	$0 0.0% of portfolio	79	Q2 2025 New
BCRX Biocryst Pharmaceuticals Inc	$1.28B	$0 0.0% of portfolio	93	Q2 2025 Reduced 31.62%
BMEA Biomea Fusion, Inc.	$38.4M	$0 0.0% of portfolio	200	Q2 2025 New
SAVA Cassava Sciences Inc	$128M	$0 0.0% of portfolio	244	Q2 2024 Reduced 3.94%
CDXS Codexis, Inc.	$148M	$0 0.0% of portfolio	200	Q3 2023 Reduced 50.0%
CGEM Cullinan Oncology, Inc.	$356M	$0 0.0% of portfolio	64	Q2 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$537M	$0 0.0% of portfolio	142	Q2 2025 Added 3,450.0%
DYN Dyne Therapeutics, Inc.	$1.2B	$0 0.0% of portfolio	62	Q2 2025 Added 129.63%
EDIT Editas Medicine, Inc.	$210M	$0 0.0% of portfolio	60	Q3 2024 Reduced 74.47%
HRTX Heron Therapeutics, Inc.	$140M	$0 0.0% of portfolio	200	Q3 2023 Reduced 75.7%
IMUX Immunic, Inc.	$21.4M	$0 0.0% of portfolio	2	Q2 2019 New
IOVA Iovance Biotherapeutics, Inc.	$308M	$0 0.0% of portfolio	86	Q1 2025 Reduced 74.48%
JAZZ Jazz Pharmaceuticals PLC	$8.64B	$0 0.0% of portfolio	2	Q2 2025 Reduced 99.22%
KYMR Kymera Therapeutics, Inc.	$3.27B	$0 0.0% of portfolio	20	Q2 2025 Reduced 28.57%
MNKD Mannkind Corp	$1.41B	$0 0.0% of portfolio	97	Q2 2025 Reduced 93.49%
ORIC Oric Pharmaceuticals, Inc.	$493M	$0 0.0% of portfolio	83	Q2 2025 New
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	295	Q2 2024 Reduced 5.14%
RGNX Regenxbio Inc.	$518M	$0 0.0% of portfolio	67	Q2 2025 Added 34.0%
RCKT Rocket Pharmaceuticals, Inc.	$269M	$0 0.0% of portfolio	230	Q2 2025 Reduced 77.71%
SLDB Solid Biosciences Inc.	$33.2M	$0 0.0% of portfolio	125	Q2 2025 Added 1,685.71%
STRO Sutro Biopharma, Inc.	$56.3M	$0 0.0% of portfolio	465	Q3 2023 Added 0.19%
SNDX Syndax Pharmaceuticals Inc	$778M	$0 0.0% of portfolio	96	Q2 2025 Reduced 71.08%
TSHA Taysha Gene Therapies, Inc.	$209M	$0 0.0% of portfolio	280	Q2 2024 New
VNDA Vanda Pharmaceuticals Inc.	$253M	$0 0.0% of portfolio	87	Q2 2023 Added 188.5%
VRDN Viridian Therapeutics, Inc.\De	$895M	$0 0.0% of portfolio	65	Q2 2025 New
WVE Wave Life Sciences Ltd.	$706M	$0 0.0% of portfolio	95	Q1 2023 New
AADI Aadi Bioscience, Inc.	$35.9M	$0 0.0% of portfolio	8	Q2 2024 Reduced 100.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.